HANCE SCARBOROUGH lobbying for ALLIANCE FOR PHARMACY COMPOUNDING

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 12, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Texas

Official filing document

Lobbyists on this filing 2

MICHAEL TOMBERLIN

Previously held: Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep., Louie Gohmert
THERESA REED

Previously held: Leg. Director for Multiple Members

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Drug Shortages SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations

Pharmacy

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Drug Shortages SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations

Budget/Appropriations

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations

Bills named in this filing 3

H.R. 6509
SAFE Drugs Act of 2025
S. 3794
SAFE Drugs Act of 2026
H.R. 5316
Drug Shortage Compounding Patient Access Act of 2025